Moyo RC

Do men face greater barriers to accessing HIV testing services than women? Might HIV self-testing be the answer? Evidence from a longitudinal survey in east Zimbabwe (2018–2023)
Otambo WO, Mandizvidza P, Moorhouse L, Inghels M, Moyo RC, Okango E, Tsenesa B, Maswera R, Dzamatira F, Gregson S, Tanser FC, Nyamukapa C, Mee P

PLOS Global Public Health

(2026)

https://doi.org/10.1371/journal.pgph.0006125
Effect of the scale-up of Dolutegravir on retention in care, risk of developing Tuberculosis and viral load suppression among people living with HIV: Analysis of routine HIV clinical data in rural KwaZulu-Natal, South Africa (2019 – 23)
Moyo RC, Okango E, Bolton L, Otto M, Blose N, Letoao NS, Otambo WO, Gareta D, Nyasulu PS, Mee P, Lessels RJ, Tanser FC

Open Forum Infectious Diseases

(2026)

https://doi.org/10.1093/ofid/ofag156
Dolutegravir rollout for treatment of HIV with a focus on advanced disease and tuberculosis coinfection: findings from rural KwaZulu-Natal, South Africa (2019– 2023)
Moyo RC, Bolton L, Okango EL, Otto M, Leoao NS, Nyasulu PS, Tanser FC

AIDS Research and Therapy

(2025)

https://doi.org/10.1186/s12981-025-00810-z
Trends in population HIV viral suppression: a longitudinal analysis
Otto M, Okango E, Mee P, Dobra A, Tram KH, Gareta D, Otambo WO, Moyo RC, Sereo TD, Blose N, Leoao NS, Mupanguri L, Mwambi H, Herbst K, Tanser FC

AIDS

(2025)

https://doi.org/10.1097/QAD.0000000000004183